Clinical Trial Update: A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navitoclax). [Phase 1]

View source ↗

Summary

Phase 1 study evaluating how ketoconazole affects the metabolism of navitoclax (ABT-263) in patients with lymphoma, chronic lymphocytic leukemia, or solid tumor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Lymphoma
• Solid Tumors

Drugs mentioned

• Ketoconazole (Ketoconazole)
• Navitoclax (navitoclax)

Snippet

Sponsor: Abbott | Conditions: Lymphoma, Chronic Lymphocytic Leukemia | Phase 1 | Status: COMPLETED